Increased urinary exosomal micrornas in patients with systemic lupus erythematosus

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Perez Hernandez, Javier ^a   Forner, Maria J ^a   Pinto, Carolina ^a   Chaves, Felipe J ^b   Cortes, Raquel ^c   Redon, Josep ^a  

^a Instituto Universitario IVI INCLIVA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 200C; MICRORNA 302D; MICRORNA 335; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXOSOME; FEMALE; GENETIC MARKER; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRACENTRIFUGATION; URINALYSIS; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; URINE;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; EXOSOMES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MICRORNAS; MIDDLE AGED;

EID: 84946565328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138618     Document Type: Article

References (43)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-233. doi:10. 1016/j.cell.2009.01.002
2. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11:441-450
3. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-355
4. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866
5. Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15:1665-1672
6. Alevizos I, Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010; 6: 391-398. doi:10.1038/nrrheum.2010.81
7. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The MicroRNA Spectrum in 12 Body Fluids. Clin Chem 2010; 56: 1733-1741. doi:10.1373/clinchem.2010.147405
8. Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 2013; 59:658-666. doi:10.1373/clinchem.2012. 195297
9. Lv LL, Cao Y, Liu D, Xu M, Liu H, Tang RN, et al. Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery. Int J Biol Sci 2013; 9:1021-1031. doi:10.7150/ijbs. 6100
10. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci 2011; 108:5003-5008. doi:10.1073/pnas.1019055108
11. Vickers KC, Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23:91-97. doi:10.1097/MOL.0b013e328350a425
12. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73:1907-1920. doi:10.1016/j.jprot.2010.06.006
13. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 2011; 9:86. doi:10.1186/1479-5876-9-86
14. Lässer C, Alikhani VS, Ekstrm K, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Transl. Med. 2011; 9:9. doi:10.1186/1479-5876-9-9
15. Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012; 40:10937-10949. doi:10.1093/nar/gks832
16. Valadi H, Ekstrm K, Bossios A, Eldh M, Paredes PT, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659
17. Lorenzen JM, Haller H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 2011; 7:286-294. doi:10.1038/nrneph.2011.26
18. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012; 81: 617-627. doi:10.1038/ki.2011. 448
19. Van Balkom BW, Pisitkun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int 2011; 80:1138-1145. doi:10.1038/ki.2011.292
20. Fang DY, King HW, Li JY, Gleadle JM. Exosomes and the kidney: blaming the messenger. Nephrology (Carlton) 2013; 18:1-10.
21. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis. Markers 2010; 28:79-86. doi:10.3233/DMA-2010-0687
22. Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, Faulhaber-Walter R, et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol 2011; 6:1540-1546. doi:10.2215/CJN.00430111
23. Neal CS, Michael MZ, PimLott LK, Yong TY, Li JYZ, Gleadle JM. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol. Dial. Transpl 2011; 26:3794-3802.
24. Barutta F, Tricarico M, Corbelli A, Annaratone L, Pinach S, Grimaldi S, et al. Urinary exosomal micro-RNAs in incipient diabetic nephropathy. PLoS One 2013; 8:e73798. doi:10.1371/journal.pone. 0073798
25. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2013; 20:493-500.
26. Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 2014; 86:433-444. doi:10.1038/ki. 2013.502
27. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis (2012). Kidney Inter. Suppl 2012; 2:139-274.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med 1999; 130:461-470
29. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci 2008; 105:10513-10518. doi:10.1073/pnas.0804549105
30. Ltvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles" provides useful advice to this end Journal of Extracellular Vesicles 2014; 3:26913. doi:10.3402/jev.v3.26913
31. Ramachandran K, Saikumar J, Bijol V, Koyner JL, Qian J, Betensky RA, et al. Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin. Chem 2013; 59: 1742-1752. doi:10.1373/clinchem.2013.210245
32. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, et al. Glomerular and tubulo interstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012; 17: 346-351.
33. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2:ra81. doi:10.1126/scisignal.2000610
34. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107:810-7. doi:10.1161/CIRCRESAHA.110.226357
35. Faherty N, Curran SP, O'Donovan H, Martin F, Godson C, Brazil DP, et al. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF type II receptor with implications for nephropathic cell phenotypes. J Cell Sci. 2012; 125:5621-9. doi:10.1242/jcs.105528
36. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of MicroRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012; 7:e30679. doi:10.1371/journal.pone.0030679
37. Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br. J. Cancer 2012; 107:123-128. doi:10.1038/bjc.2012.221
38. Sugiyama R H, Blank A, Dekker CA. Multiple ribonucleases of human urine. Biochemistry 1981; 20, 2268-2274
39. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 2012; 82:1024-1032. doi:10.1038/ki.2012.256
40. Wang H, Peng W, Ouyang X, Li W, Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 2012; 160:198-206 doi:10.1016/j.trsl.2012.04.002
41. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010; 5:e10344. doi:10.1371/journal. pone.0010344
42. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013; 4:2980. doi:10.1038/ncomms3980
43. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signalling proteins. Arthritis Rheum 2009; 60:1065-1075. doi:10.1002/art.24436